« Back
Home /
Serdemetan (JNJ-26854165)

Serdemetan (JNJ-26854165)

Item no.	S1172-10mM
Manufacturer	Selleckchem
CASRN	881202-45-5
Amount	10 mM/1 ml
Quantity options	100 mg 1 g 10 g 10 mM/1 ml 25 mg 5 mg 5 g
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Bladder Cancer Colorectal Cancer Breast Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Smiles	C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	881202-45-5'
Similar products	881202-45-5
Available
Storage Conditions	2 years -80 in solvent
Information	Serdemetan (JNJ-26854165) acts as a HDM2 ubiquitin ligase antagonist and also induces early apoptosis in p53 wild-type cells, inhibits cellular proliferation followed by delayed apoptosis in the absence of functional p53. Phase 1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

S1172-10mM-datasheet.pdf

S1172-10mM-safety-datasheet.pdf